Michele Perry Williams

FDA investigator

Appears on 22 documents from 2009 to 2023, mostly at sites in Missouri. Most often cites production record review (21 CFR 211.192).

22
Documents on file
9.8
Observations per 483
2009
First seen
2023
Most recent

What they cite most

From 195 observations

Activity by year

2009: 1, 2013: 3, 2014: 1, 2016: 2, 2017: 3, 2018: 4, 2019: 1, 2020: 2, 2022: 2, 2023: 3

Where

Missouri 11 · Illinois 3 · Japan 3 · Kansas 3 · Indiana 1 · Minnesota 1

Is Michele Perry Williams coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

22 documents, newest first
FirmOpen
483 Takeda Pharmaceutical Company Limi t edNov 6, 2023 · Hikari, Japan
483 Rohto Pharmaceutical Co., Ltd.Mar 8, 2023 · Iga, Japan
483 TOYOBO CO., LTD.Feb 25, 2023 · Otsu, Japan
483 ANI Pharmaceuticals, Inc.Nov 18, 2022 · Baudette, Minnesota
483 Marcus Research Laboratory, Inc.Sep 2, 2022 · Saint Louis, Missouri
483 Reliable Biopharmaceutical, LLCFeb 21, 2020 · St. Louis, Missouri
483 Apertus Pharmaceuticals, LLCJan 16, 2020 · Ballwin, Missouri

About this profile

What does Michele Perry Williams inspect?

Michele Perry Williams appears on 22 documents on file covering 18 sites, mostly in Missouri.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.113 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Michele Perry Williams is dated Nov 6, 2023.